Article
No more injections after one-off gene therapy in hemophilia B
“Normal factor IX levels can be achieved in patients with severe or moderately severe hemophilia B with the use of relatively low vector doses of...
“Normal factor IX levels can be achieved in patients with severe or moderately severe hemophilia B with the use of relatively low vector doses of...
New American Gastroenterological Association document suggests dropping GERD as a prerequisite for screening, among other advice statements.
Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for...
The Apollo Endosurgery devices are the first and only ones approved for endoscopic sleeve gastroplasty and endoscopic bariatric revision, the...
The study results support carrying out large, well-designed, rigorously designed trials.
Segmental colectomy may be performed in patients with colonic Crohn’s disease without increasing risk of repeat surgeries, compared with total...
While tyrosine kinase inhibitors were found to be associated with more serious adverse events, both treatments had similar toxic effects.
Keeping a deceased recipient in a brain-dead state is part of xenotransplantation research, but experts debate the question: For how long, and...
Phase 2 trial offers hope of a chemotherapy-free option for patients with advanced NSCLC.
“We have a couple dozen patients who are 5, 6, 7, 9 years out or more without further therapy. That feels like a cure to me.”